Widespread expression of erythropoietin receptor in brain and its induction by injury

Molecular Medicine

Volumn 21, Issue , 2015, Pages 803-815

  Ott, Christoph ^a   Martens, Henrik ^b   Hassouna, Imam ^a,c   Oliveira, Bárbara ^a   Erck, Christian ^b   Zafeiriou, Maria Patapia ^d   Peteri, Ulla Kaisa ^a   Hesse, Dörte ^a   Gerhart, Simone ^a   Altas, Bekir ^a   Kolbow, Tekla ^b   Stadler, Herbert ^b   Kawabe, Hiroshi ^a   Zimmermann, Wolfram Hubertus ^d   Nave, Klaus Armin ^a,e   Schulz Schaeffer, Walter ^d   Jahn, Olaf ^a,e   Ehrenreich, Hannelore ^a,e  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b SYNAPTIC SYSTEMS GMBH   (Germany)

^c Menoufia University   (Egypt)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e Deutsche Forschungsgemeinschaft   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN ANTIBODY; ERYTHROPOIETIN RECEPTOR; KRUPPEL LIKE FACTOR 4; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; FOCAL EPILEPSY; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MICROGLIA; MOTOR CORTEX; NERVE CELL; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE SECTION; UPREGULATION; WESTERN BLOTTING;

EID: 84975105873     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2015.00192     Document Type: Article

References (43)

1. Brines M, Cerami A. (2005) Emerging biological roles for erythropoietin in the nervous system. Nat. Rev. Neurosci. 6:484-94.
2. Jelkmann W. (2007) Erythropoietin after a century of research: younger than ever. Eur. J. Haematol. 78:183-205.
3. Jelkmann W. (2013) Physiology and pharmacology of erythropoietin. Transfus. Med. Hemother. 40:302-9.
4. Arcasoy MO. (2008) The non-haematopoietic biological effects of erythropoietin. Br. J. Haematol. 141:14-31.
5. Sargin D, Friedrichs H, El-Kordi A, Ehrenreich H. (2010) Erythropoietin as neuroprotective and neu-roregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Pract. Res. Clin. Anaesthesiol. 24:573-94.
6. Siren AL, Fasshauer T, Bartels C, Ehrenreich H. (2009) Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics. 6:108-27.
7. Miskowiak KW, Vinberg M, Harmer CJ, Ehrenreich H, Kessing LV. (2012) Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression. Psychopharmacology (Berl.). 219:687-98.
8. D’Andrea AD, Lodish HF, Wong GG. (1989) Expression cloning of the murine erythropoietin receptor. Cell. 57:277-85.
9. Jones SS, D’Andrea AD, Haines LL, Wong GG. (1990) Human erythropoietin receptor: cloning, expression, and biologic characterization. Blood. 76:31-5.
10. Noguchi CT, et al. (1991) Cloning of the human erythropoietin receptor gene. Blood. 78:2548-56.
11. Elliott S, et al. (2010) Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells. J. Immunol. Methods 352:126-39.
12. Noguchi CT, Wang L, Rogers HM, Teng R, Jia Y. (2008) Survival and proliferative roles of erythropoietin beyond the erythroid lineage. Expert Rev. Mol. Med. 10:e36.
13. Siren AL, et al. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U. S. A. 98:4044-9.
14. Elliott S, et al. (2006) Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood. 107:1892-5.
15. Sinclair AM, et al. (2010) Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells. Blood. 115:4264-72.
16. Ghezzi P, et al. (2010) Erythropoietin: not just about erythropoiesis. Lancet. 375:2142.
17. Kirkeby A, van Beek J, Nielsen J, Leist M, Helboe L. (2007) Functional and immunochemical characterisation of different antibodies against the erythropoietin receptor. J. Neurosci. Methods. 164:50-8.
18. Brown WM, et al. (2007) Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity. Stem Cells. 25:718-22.
19. Yu X, et al. (2002) Erythropoietin receptor signalling is required for normal brain development. Development. 129:505-16.
20. Tsai PT, et al. (2006) A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J. Neurosci. 26:1269-74.
21. Ehrenreich H, et al. (2005) A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc. Natl. Acad. Sci. U. S. A. 102:862-7.
22. Digicaylioglu M, et al. (1995) Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. Natl. Acad. Sci. U. S. A. 92:3717-20.
23. Ehrenreich H, et al. (2004) Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol. Psychiatry. 9:42-54.
24. Mitkovski M, et al. (2015) Erythropoietin dampens injury-induced microglial motility. J. Cereb. Blood Flow Metab. 35:1233-6.
25. Aggarwal S, et al. (2013) Myelin membrane assembly is driven by a phase transition of myelin basic proteins into a cohesive protein meshwork. PLoS Biol. 11:e1001577.
26. Pyott SJ, Rosenmund C. (2002) The effects of temperature on vesicular supply and release in autaptic cultures of rat and mouse hippocampal neurons. J. Physiol. 539:523-5.
27. Becker V, et al. (2010) Covering a broad dynamic range: information processing at the erythropoietin receptor. Science. 328:1404-8.
28. Huang W, et al. (2014) Novel NG2-CreERT2 knock-in mice demonstrate heterogeneous differentiation potential of NG2 glia during development. Glia. 62:896-913.
29. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. (2007) A global double-fluorescent Cre reporter mouse. Genesis. 45:593-605.
30. Wessel D, Flugge UI. (1984) A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138:141-3.
31. Schmidt C, Hesse D, Raabe M, Urlaub H, Jahn O. (2013) An automated in-gel digestion/iTRAQlabeling workflow for robust quantification of gel-separated proteins. Proteomics. 13:1417-22.
32. Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ. (2006) Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol. Cell Proteomics. 5:144-56.
33. Silva JC, et al. (2005) Quantitative proteomic analysis by accurate mass retention time pairs. Anal. Chem. 77:2187-200.
34. Geromanos SJ, Hughes C, Ciavarini S, Vissers JP, Langridge JI. (2012) Using ion purity scores for enhancing quantitative accuracy and precision in complex proteomics samples. Anal. Bioanal. Chem. 404:1127-39.
35. Distler U, et al. (2014) Drift time-specific collision energies enable deep-coverage data-independent acquisition proteomics. Nat. Methods. 11:167-70.
36. Li GZ, et al. (2009) Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures. Proteomics. 9:1696-719.
37. Maxwell P, et al. (2015) Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation. Br. J. Haematol. 168:429-42.
38. Saper CB. (2005) An open letter to our readers on the use of antibodies. J. Comp. Neurol. 493:477-8.
39. Siren AL, et al. (2001) Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol. 101:271-6.
40. Shingo T, Sorokan ST, Shimazaki T, Weiss S. (2001) Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J. Neurosci. 21:9733-43.
41. Ransome MI, Turnley AM. (2007) Systemically delivered Erythropoietin transiently enhances adult hippocampal neurogenesis. J. Neurochem. 102:1953-65.
42. Jantzie LL, Miller RH, Robinson S. (2013) Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxicischemic brain injury. Pediatr. Res. 74:658-67.
43. Kako E, et al. (2012) Subventricular zone-derived oligodendrogenesis in injured neonatal white matter in mice enhanced by a nonerythropoietic erythropoietin derivative. Stem Cells. 30:2234-47.